Skip to main content

Month: March 2021

Gulf Island Reports Fourth Quarter 2020 Results

Fourth Quarter 2020 Highlights and Recent DevelopmentsContinued focus on centralizing key resources and improving utilizationPreviously announced closure of Jennings facility completed in the fourth quarter 2020 Closure of Lake Charles facility announced and completed in the fourth quarter 2020Improved performance for the Fabrication & Services Division Final two harbor tugs completed within the Shipyard Division Change order finalized with the U.S. Navy in March 2021, providing anticipated first quarter 2021 benefitHOUSTON, March 29, 2021 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ: GIFI) today reported results for the fourth quarter and full year 2020.Operating Results(in thousands, except per share data)   Three Months Ended December 31,     Years...

Continue reading

Handprint, a business unit of UFP Industries, announces agreement to purchase Walnut Hollow Farm

GRAND RAPIDS, Mich., March 29, 2021 (GLOBE NEWSWIRE) — UFP Industries, Inc. (Nasdaq: UFPI) today announced that Handprint, the growing home and décor business unit of UFP Retail Solutions, has signed an agreement to purchase the operating assets of Walnut Hollow Farm, Inc. Pending customary closing conditions, the acquisition is expected to close by the end of April 2021. Founded by the Ladd family in 1972 and based in Dodgeville, Wisconsin, Walnut Hollow produces a variety of finely finished wood surfaces used in hobby, craft and woodworking projects, as well as in taxidermy. The company also sells its own line of woodburning tools and accessories. Walnut Hollow had sales of approximately $11 million in 2020. President Sandra Ladd Bartelt and CFO Chris Ladd will leave the company and continue to serve as consultants for a specified...

Continue reading

Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology

NEW HAVEN, Conn., March 29, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced the publication of research validating the ability of the company’s xB3 ™ platform to efficiently deliver siRNA across the blood-brain barrier to the central nervous system in therapeutically relevant doses. Scientists from Bioasis and Dr. Wilfred A. Jefferies evaluated Bioasis’ xB3 ™ platform technology by investigating its application to siRNA brain...

Continue reading

Evo Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing April 1, 2021

Crystal Bay, Nevada, March 29, 2021 (GLOBE NEWSWIRE) — Evo Acquisition Corp. (NASDAQ: EVOJU) (the “Company”) announced that, commencing April 1, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of Class A common stock and warrants that are separated will trade on the Nasdaq Capital Market under the symbols “EVOJ” and “EVOJW,” respectively. Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol “EVOJU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to...

Continue reading

Alpine Income Property Trust Announces First Quarter 2021 Earnings Release and Conference Call Information

DAYTONA BEACH, Fla., March 29, 2021 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the first quarter 2021 after the market closes on Thursday, April 22, 2021. A conference call to discuss its financial and operating results is scheduled for Friday, April 23, 2021 at 9:00 AM ET (the “Earnings Call”). Shareholders and interested parties may access the Earnings Call via teleconference or webcast:Teleconference: USA (Toll Free) 1-888-317-6003  International 1-412-317-6061  Canada (Toll Free) 1-855-669-9657To access the conference call, enter 0658375 when prompted. To participate via teleconference, please dial-in approximately 10 minutes prior to the scheduled time of the Earnings Call. To access the webcast, log...

Continue reading

Kinnate Biopharma Inc. Reports Full Year 2020 Financial Results

Completed recent IPO, raising $276MM in gross proceeds to fund kinase inhibitors for genomically defined cancers Progress towards IND filing for KIN-2787, our RAF inhibitor candidate, in the first half of 2021 and initiating a Phase 1 clinical trial later in the year remains on track Selected KIN-3248 as our lead FGFR inhibitor candidate; anticipate IND filing in the first half of 2022 SAN FRANCISCO and SAN DIEGO, March 29, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced financial results for the full year ended December 31, 2020. “Since completing our IPO last year, we entered 2021 well-funded to advance the development of our lead...

Continue reading

AgJunction Appoints Cheryne Lowe as Interim CFO

SCOTTSDALE, Ariz., March 29, 2021 (GLOBE NEWSWIRE) — AgJunction Inc. (TSX: AJX) (“AgJunction” or the “Company”) today announced that it has appointed Cheryne Lowe as interim chief financial officer of the Company, replacing the former interim chief financial officer, Peter Newton, whose contract has concluded. Ms. Lowe has nearly twenty years of experience in finance, including roles at a big four accounting firm and CFO of a publicly-traded company on the Toronto Stock Exchange. AgJunction continues its previously announced search for a permanent CFO in the greater Scottsdale area. The Company thanks Mr. Newton for his contributions and wishes him the best in the future. About AgJunction AgJunction Inc. is a global leader of advanced guidance and autosteering solutions for precision agriculture applications....

Continue reading

CTO Realty Growth Announces First Quarter 2021 Earnings Release and Conference Call Information

DAYTONA BEACH, Fla., March 29, 2021 (GLOBE NEWSWIRE) — CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the first quarter 2021 after the market closes on Thursday, April 29, 2021. A conference call to discuss its financial and operating results is scheduled for Friday, April 30, 2021 at 9:00 AM ET (the “Earnings Call”). Shareholders and interested parties may access the Earnings Call via teleconference or webcast: To participate via teleconference, please dial-in approximately 10 minutes prior to the scheduled time of the Earnings Call. To access the webcast, log on to the web address noted above or go to www.ctoreit.com and log in at the investor relations section. A replay of the Earnings Call will be archived and available online through the Investor Relations...

Continue reading

Leonovus Announces Up to $4 Million Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OTTAWA, March 29, 2021 (GLOBE NEWSWIRE) — Leonovus Inc. (TSXV:LTV) (the “Company” or “Leonovus”), is pleased to announce that it has filed and been receipted for a preliminary short form prospectus with the securities regulatory authorities in all provinces of Canada (except Québec) in connection with a marketed public offering (the “Offering”) of units of the Company (“Units”) priced in the context of the market, at an indicative price of $0.68 per Unit, for gross proceeds of up to $4,000,000. The Offering is being led by Mackie Research Capital Corporation as lead agent and sole bookrunner (the “Lead Agent”), on behalf of a syndicate of agents, including...

Continue reading

Quisitive Announces Agreement to Acquire BankCard USA

Transformative Transaction for Quisitive’s LedgerPay Payment Solutions Subsidiary THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTIONTO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.Acquisition of BankCard USA establishes Quisitive as a payment technology leader Strong alignment with Quisitive’s Payments Solutions business plan and LedgerPay growth strategy BankCard USA processes over US$3.0 billion of payments annually for a diverse client base and has a strong in-house sales force LTM Revenue of US$29 million and LTM Adjusted EBITDA of US$11 million for the 12-month period ended September 30, 2020 Expected to provide meaningful synergiesTORONTO, March 29, 2021 (GLOBE NEWSWIRE) — Quisitive Technology Solutions Inc. (“Quisitive” or the “Company”) (TSXV: QUIS)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.